Kevin D'Amour is the founder of Novellus. Novellus has raised $57M in total funding. Latest round: Series C.
Kevin A. D'Amour is a biotechnology executive and scientist specializing in therapeutic development. He served as chief scientific officer at Brooklyn ImmunoTherapeutics in 2021 and later joined Stemson Therapeutics as chief scientific officer. The provided sources do not confirm a current role at Novellus.
Full founder directory · Investor directory · Company funding database · Fundraising library